Roxanne Shurtliff

Introduction

Roxanne Shurtliff, an innovative inventor based in Herndon, VA, is making a significant impact in the field of biomedical research. With a total of four patents to her name, her work primarily focuses on developing advanced assays for the detection and quantification of specific chemokines, which are essential for understanding various biological processes.

Latest Patents

Her most recent patents include the development of isothermal transcription-based assays for the detection and quantification of chemokines, specifically RANTES, MIP-1α, and MIP-1β. These innovative assays utilize primers and probes designed for sequences within the genes of RANTES, MIP-1α, and MIP-1β, providing a quantitative system that incorporates an internal control Q using a mutant version of each gene. The target-specific primers and probes disclosed in her patents enhance the accuracy and reliability of chemokine RNA detection.

Career Highlights

Roxanne Shurtliff's career is marked by her dedication to advancing scientific knowledge through her inventions. As a key member of the team at Akzo Nobel N.V., she applies her expertise in molecular biology to develop cutting-edge technologies aimed at improving health diagnostics.

Collaborations

Throughout her career, Roxanne has collaborated with notable colleagues, including Joseph W. Romano and Kimberly G. Williams. These professional partnerships have played a key role in her research endeavors, driving innovation and fostering a collaborative environment for scientific exploration.

Conclusion

Roxanne Shurtliff exemplifies the spirit of innovation in the field of biomedicine. Her contributions, particularly through her recent patents, are paving the way for improved methods of chemokine detection, which have significant implications for research and therapeutic advancements. Her work at Akzo Nobel N.V. ensures that her valuable inventions continue to progress and impact the scientific community positively.